Carving Parameterized Unit Tests

We present a method to automatically extract ("carve") parameterized unit tests from system test executions. The unit tests execute the same functions as the system tests they are carved from, but can do so much faster as they call functions directly; furthermore, being parameterized, they can execute the functions with a large variety of randomly selected input values. If a unit-level test fails, we lift it to the system level to ensure the failure can be reproduced there. Our method thus allows to focus testing efforts on selected modules while still avoiding false alarms: In our experiments, running parameterized unit tests for individual functions was, on average, 30~times faster than running the system tests they were carved from

From Input Coverage to Code Coverage: Systematically Covering Input Structure with k-Paths

Grammar-based testing uses a given grammar to produce syntactically valid inputs. Intuitively, to cover program features, it is necessary to also cover input features. We present a measure of input coverage called k-path coverage, which takes into account the coverage of individual syntactic elements as well as their combinations up to a given depth k. A k-path coverage with k = 1 prescribes that all individual symbols be covered; k-path coverage with k = 2 dictates that all symbols in the context of all their parents be covered; and so on. Using the k-path measure, we make a number of contributions. (1) We provide an \emph{algorithm for grammar-based production} that constructively covers a given k-path measure. In our evaluation, using k-path during production results in a significantly higher code coverage than state-of-the-art approaches that ignore input coverage. (2) We show on a selection of real-world subjects that coverage of input elements, as measured by k-path, correlates with code coverage. As a consequence, k-path coverage can also be used to predict code coverage. (3) We show that one can learn associations between individual k-path features and coverage of specific locations: "Method `distrule` is invoked whenever both `+` and `*` occur in an expression." Developers can interpret these associations to create suitable inputs that focus on selected methods, or have tools generate inputs that immediately target these methods. The above approaches have been implemented in the \tribble and \codeine prototypes, and evaluated on a number of processors for JSON, CSV, URLs, and Markdown. All tools and data are available as open source

Literaturrundschau

Kloock: Von der Schrift- zur Bild(schirm)kultur. Analyse aktueller MedientheorienPüttmann: Auf Vermittler angewiesen. Wie entsteht öffentliche Meinung über die KircheLiteratur zur kirchlichen Öffentlichkeitsarbeit. Eine Kommentierung derzeit erhältlicher BücherDorni Eberts: Redaktionshandbuch Katholische Kirche. Zum Nachschlagen und NachdruckenKURZBESPRECHUNGENBundeszentrale für politische Bildung: Vox Populi. Hörerinnen und Hörer haben das Wort. Reader für die Radio-PraxisOrians: Hörerbeteiligung im Radio. Eine Fallstudie zu Motivation, Erwartung und Zufriedenheit von Anrufer

Alendronate reduces periosteal microperfusion in vivo

OBJECTIVES: Bisphosphonates are known to induce a severe adverse effect known as medication-related osteonecrosis of the jaw (MRONJ). Previous studies have proven the impact of bisphosphonates on microperfusion; therefore, this study aimed to investigate alendronate-induced microcirculatory reactions in the calvarial periosteum of rats. STUDY DESIGN: Bone chambers were implanted into 48 Lewis rats. Microhemodynamics, inflammatory parameters, functional capillary density and defect healing were examined after alendronate treatment for two and six weeks using repetitive intravital fluorescence microscopy for two weeks. RESULTS: Microhemodynamics remained unchanged. In alendronate-treated rats, inflammation was slightly increased, functional capillary density was significantly reduced (day 10: controls 100.45 ± 5.38 cm/cm$^{2}$, two weeks alendronate treatment 44.77 ± 3.55 cm/cm$^{2}$, six weeks alendronate treatment 27.54 ± 2.23 cm/cm$^{2}$) and defect healing was decelerated. The changes in functional capillary density and defect healing were dose-dependent. CONCLUSION: The bisphosphonate alendronate has a significant negative impact on periosteal microperfusion in vivo. This could be a promising target for the treatment of MRONJ

Overexpression of heat shock protein 27 (HSP27) increases gemcitabine sensitivity in pancreatic cancer cells through S-phase arrest and apoptosis

We previously established a role for HSP27 as a predictive marker for therapeutic response towards gemcitabine in pancreatic cancer. Here, we investigate the underlying mechanisms of HSP27-mediated gemcitabine sensitivity. Utilizing a pancreatic cancer cell model with stable HSP27 overexpression, cell cycle arrest and apoptosis induction were analysed by flow cytometry, nuclear staining, immunoblotting and mitochondrial staining. Drug sensitivity studies were performed by proliferation assays. Hyperthermia was simulated using mild heat shock at 41.8 degrees C. Upon gemcitabine treatment, HSP27-overexpressing cells displayed an early S-phase arrest subsequently followed by a strongly increased sub-G1 fraction. Apoptosis was characterized by PARP-, CASPASE 3-, CASPASE 8-, CASPASE 9- and BIM- activation along with a mitochondrial membrane potential loss. It was reversible through chemical caspase inhibition. Importantly, gemcitabine sensitivity and PARP cleavage were also elicited by heat shock-induced HSP27 overexpression, although to a smaller extent, in a panel of pancreatic cancer cell lines. Finally, HSP27-overexpressing pancreatic cancer cells displayed an increased sensitivity also towards death receptor-targeting agents, suggesting another pro-apoptotic role of HSP27 along the extrinsic apoptosis pathway. Taken together, in contrast to the well-established anti-apoptotic properties of HSP27 in cancer, our study reveals novel pro-apoptotic functions of HSP27mediated through both the intrinsic and the extrinsic apoptotic pathwaysat least in pancreatic cancer cells. HSP27 could represent a predictive marker of therapeutic response towards specific drug classes in pancreatic cancer and provides a novel molecular rationale for current clinical trials applying the combination of gemcitabine with regional hyperthermia in pancreatic cancer patients

Role of human milk oligosaccharides in Group B Streptococcus colonisation.

Group B Streptococcus (GBS) infection is a major cause of morbidity and mortality in infants. The major risk factor for GBS disease is maternal and subsequent infant colonisation. It is unknown whether human milk oligosaccharides (HMOs) protect against GBS colonisation. HMO production is genetically determined and linked to the Lewis antigen system. We aimed to investigate the association between HMOs and infant GBS colonisation between birth and postnatal day 90. Rectovaginal swabs were collected at delivery, as well as colostrum/breast milk, infant nasopharyngeal and rectal swabs at birth, 6 days and days 60-89 postpartum from 183 Gambian mother/infant pairs. GBS colonisation and serotypes were determined using culture and PCR. (1)H nuclear magnetic resonance spectroscopy was used to characterise the mother's Lewis status and HMO profile in breast milk. Mothers who were Lewis-positive were significantly less likely to be colonised by GBS (X (2)=12.50, P<0.001). Infants of Lewis-positive mothers were less likely GBS colonised at birth (X (2)=4.88 P=0.03) and more likely to clear colonisation between birth and days 60-89 than infants born to Lewis-negative women (P=0.05). There was no association between Secretor status and GBS colonisation. In vitro work revealed that lacto-N-difucohexaose I (LNDFHI) correlated with a reduction in the growth of GBS. Our results suggest that HMO such as LNDFHI may be a useful adjunct in reducing maternal and infant colonisation and hence invasive GBS disease. Secretor status offers utility as a stratification variable in GBS clinical trials

Comparison of Selective Laser Melted Titanium and Magnesium Implants Coated with PCL

Degradable implant material for bone remodeling that corresponds to the physiological stability of bone has still not been developed. Promising degradable materials with good mechanical properties are magnesium and magnesium alloys. However, excessive gas production due to corrosion can lower the biocompatibility. In the present study we used the polymer coating polycaprolactone (PCL), intended to lower the corrosion rate of magnesium. Additionally, improvement of implant geometry can increase bone remodeling. Porous structures are known to support vessel ingrowth and thus increase osseointegration. With the selective laser melting (SLM) process, defined open porous structures can be created. Recently, highly reactive magnesium has also been processed by SLM. We performed studies with a flat magnesium layer and with porous magnesium implants coated with polymers. The SLM produced magnesium was compared with the titanium alloy TiAl6V4, as titanium is already established for the SLM-process. For testing the biocompatibility, we used primary murine osteoblasts. Results showed a reduced corrosion rate and good biocompatibility of the SLM produced magnesium with PCL coating.DFG/299/11-

Prevalence of Uncontrolled Hypertension in Patients With Fabry Disease

Background: Fabry disease is a rare X-linked disease arising from deficiency of α-galactosidase A. It results in early death related to renal, cardiac, and cerebrovascular disease, which are also important outcomes in patients with elevated blood pressure (BP). The prevalence of uncontrolled hypertension, as well as the effect of enzyme replacement therapy on BP, in patients with Fabry disease is unknown. Methods: We examined uncontrolled hypertension (systolic BP [SBP] ≥130 mm Hg or diastolic BP [DBP] ≥80 mm Hg) among 391 patients with Fabry disease who were participating in the Fabry Outcome Survey (FOS). Results: Uncontrolled hypertension was present in 57% of men and 47% of women. In patients with chronic kidney disease (CKD) stage 1 (n100), median SBP was 120 mm Hg and median DBP was 74 mm Hg. In patients with CKD stage 2 (n172), median SBP was 125 mm Hg and median DBP was 75 mm Hg. In patients with CKD stage 3 (n63), median SBP was 130 mm Hg and median DBP was 75 mm Hg. There was a significant decrease in both SBP and DBP during a 2-year course of enzyme replacement therapy. Conclusions: This study revealed a high prevalence of uncontrolled hypertension among patients with Fabry disease. Thus there is a need to improve BP control and renoprotection in patients with Fabry diseas